1. Surgical and radiosurgical treatment strategies for Cushing’s disease

   • Adomas Bunevicius
   • Edward R. Laws
   • Jason Sheehan

   Topic Review 01 November 2019 Pages: 403 - 413

   

2. Radiation chronotherapy—clinical impact of treatment time-of-day: a systematic review

   • Dorela D. Shuboni-Mulligan
   • Ghislain Breton
   • Terri S. Armstrong

   Topic Review 15 November 2019 Pages: 415 - 427

   

3. Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function

   • Hillary G. Caruso
   • Ryuma Tanaka
   • Amy B. Heimberger

   Laboratory Investigation 04 November 2019 Pages: 429 - 439

   

4. Increased ¹⁴C-acetate accumulation in IDH-mutated human glioblastoma: implications for detecting IDH-mutated glioblastoma with ¹¹C-acetate PET imaging

   • Sho Koyasu
   • Yoichi Shimizu
   • Hiroshi Harada

   Laboratory Investigation 30 October 2019 Pages: 441 - 447

   

5. Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma

   • Anne Guyot
   • Mathilde Duchesne
   • François Labrousse

   Laboratory Investigation 15 November 2019 Pages: 449 - 459

   

6. White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab

   • Fayez Estephan
   • Xiaobu Ye
   • Matthias Holdhoff

   Clinical Study 16 October 2019 Pages: 461 - 466

   

7. Correction to: White matter changes in primary central nervous system lymphoma patients treated with high-dose methotrexate with or without rituximab

   • Fayez Estephan
   • Xiaobu Ye
   • Matthias Holdhoff

   Correction 22 November 2019 Pages: 467 - 467

8. Microscopic brain invasion in meningiomas previously classified as WHO grade I is not associated with patient outcome

   • Annamaria Biczok
   • Christine Jungk
   • Christian Schichor

   Clinical Study 11 November 2019 Pages: 469 - 477

   

9. Association between extent of resection on survival in adult brainstem high-grade glioma patients

   • Joshua Doyle
   • Adham M. Khalafallah
   • Debraj Mukherjee

   Clinical Study 16 October 2019 Pages: 479 - 486

   

10. Complementary and alternative medicine use in glioma patients in France

    • Emilie Le Rhun
    • Patrick Devos
    • Michael Weller

    Clinical Study 21 October 2019 Pages: 487 - 499

    

11. Observation after surgery for low grade glioma: long-term outcome in the light of the 2016 WHO classification

    • Elena Jansen
    • Christina Hamisch
    • Stefan J. Grau

    Clinical Study 16 October 2019 Pages: 501 - 507

    

12. Analysis of intra-operative variables as predictors of 30-day readmission in patients undergoing glioma surgery at a single center

    • Iahn Cajigas
    • Anil K. Mahavadi
    • Richard H. Epstein

    Clinical Study 22 October 2019 Pages: 509 - 518

    

13. Evaluating pediatric spinal low-grade gliomas: a 30-year retrospective analysis

    • Steven S. Carey
    • Zsila Sadighi
    • Ibrahim Qaddoumi

    Clinical Study 22 October 2019 Pages: 519 - 529

    

14. Longitudinal analysis of quality of life following treatment with Asunercept plus reirradiation versus reirradiation in progressive glioblastoma patients

    • Wolfgang Wick
    • Andriy Krendyukov
    • Harald Fricke

    Clinical Study Open access 02 November 2019 Pages: 531 - 540

    

15. Mortality patterns in long-term survivors of childhood or adolescent central nervous system tumour in Sweden

    • Wuqing Huang
    • Jan Sundquist
    • Jianguang Ji

    Clinical Study Open access 01 November 2019 Pages: 541 - 549

    

16. Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases

    • Christian Iorio-Morin
    • Rosalie Mercure-Cyr
    • David Mathieu

    Clinical Study 30 October 2019 Pages: 551 - 559

    

17. Cultivating resiliency in patients with neurofibromatosis 2 who are deafened or have severe hearing loss: a live‑video randomized control trial

    • Jonathan Greenberg
    • Sarah Carter
    • Ana-Maria Vranceanu

    Clinical Study 01 November 2019 Pages: 561 - 569

    

18. Fractionated stereotactic radiosurgery for malignant gliomas: comparison with single session stereotactic radiosurgery

    • Seung Won Choi
    • Kyung Rae Cho
    • Jung-Il Lee

    Clinical Study 08 November 2019 Pages: 571 - 579

    

19. Extent of surrounding edema does not correlate with acute complications after radiosurgery for melanoma brain metastases

    • Amelia Jardim
    • Justin Scott
    • Mark B. Pinkham

    Clinical Study 05 November 2019 Pages: 581 - 585

    

20. EGFR gene amplification in monocentric and multicentric glioblastoma

    • Lucia Nichelli
    • Didier Dormont
    • Anna Luisa Di Stefano

    Letter to the Editor 15 November 2019 Pages: 587 - 589

    

21. Diagnostic delay in children with central nervous system tumors and the need to improve education

    • Ibrahim Qaddoumi
    • Thomas E. Merchant
    • Amar Gajjar

    Letter to the Editor 05 November 2019 Pages: 591 - 592

22. Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016

    • Roberta Rudà
    • Alessia Pellerino
    • Riccardo Soffietti

    Correction 05 November 2019 Pages: 593 - 593

23. Correction to: Efficacy of Dabrafenib for three children with brainstem BRAF^V600E positive ganglioglioma

    • Philippe Laflamme
    • Maria Kondyli
    • Valérie Larouche

    Correction 25 November 2019 Pages: 595 - 595